Y10S977/802 - CPC Classification Index

ClassID:

243590 ⎘

Y10S977/802 - CPC Classification

Classification description:

Nanotechnology; Nanostructure; Of specified organic or carbon-based composition Virus-based particle

Sub-classes:

Y10S977/803 » Containing biological material in its interior 8
Y10S977/806 » with exterior chemical attachment 2

Recent Application in this class:

20160208009

2016-07-21

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

20150104783

2015-04-16

Apparatus and method for virus detection

20120315335

2012-12-13

SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM

20120264166

2012-10-18

Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications

20120122206

2012-05-17

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

20110294984

2011-12-01

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

20110293733

2011-12-01

SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM

20110165197

2011-07-07

Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines

20110142825

2011-06-16

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#10

20090304690

2009-12-10

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#11

20090280163

2009-11-12

High-Efficiency Fusogenic Vesicles, Methods of Producing Them, and Pharmaceutical Compositions Containing Them

#12

20090269619

2009-10-29

Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications

#13

20090252761

2009-10-08

Papilloma virus vaccine

#14

20090191226

2009-07-30

ADJUVANT FORMULATION COMPRISING A SUBMICRON OIL DROPLET EMULSION

#15

20090028894

2009-01-29

Papilloma virus capsomere vaccine formulations and methods of use

#16

20080318275

2008-12-25

Hepatitis C virus asialoglycoproteins

#17

20080213306

2008-09-04

Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines

#18

20080145387

2008-06-19

Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines

#19

20070269370

2007-11-22

Compositions and methods for treating B-cell malignancies

#20

20070154902

2007-07-05

Papilloma virus vaccine

#21

20070148145

2007-06-28

Protein modulators of resistance to alkylating agents

#22

20070129321

2007-06-07

Nanoarrays of single virus particles, methods and instrumentation for the fabrication and use thereof

#23

20060292174

2006-12-28

Self-assembling nanoparticle drug delivery system

#24

20060198853

2006-09-07

Papilloma virus capsomere vaccine formulations and methods of use

#25

20060182764

2006-08-17

Vaccines containing ribavirin and methods of use thereof

#26

20060093590

2006-05-04

Pseudotyped retrovirus with modified ebola glycoprotein

#27

20050170336

2005-08-04

Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications

#28

20050089843

2005-04-28

Antibodies to hepatitis C virus asialoglycoproteins

#29

20050079605

2005-04-14

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#30

20050074843

2005-04-07

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

#31

20050064024

2005-03-24

High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them

#32

20050031636

2005-02-10

Papilloma virus capsomere vaccine formulations and methods of use